Skip to main content

Table 4 Hazard Ratios (HR) accounting for death as a competing risk from multivariable Cox models, adjusting for the baseline data including age, gender, BMI and other available patient characteristics

From: Outcomes of patients with active cancers and pre-existing cardiovascular diseases infected with SARS-CoV-2

Stroke

HR

p-value

CVD (-)

Reference

 

CVD ( +)

0.789

< 0.0001

Cardioonc ( +)

0.901

0.2958

Cardioonc (-)

0.912

< 0.0001

Acute Heart Failure

 CVD (-)

Reference

 

 CVD ( +)

0.7598

< 0.0001

 Cardioonc ( +)

0.6513

< 0.0001

 Cardioonc (-)

0.813

< 0.0001

Myocardial Infarction

 CVD (-)

Reference

 

 CVD ( +)

0.7292

< 0.0001

 Cardioonc ( +)

0.9675

0.6659

 Cardioonc (-)

1.0633

< 0.0001

  1. CVD (-) Cardiovascular Disease and SARS-CoV-2 negative, Cardioonc (-) Cardiovascular Disease and Active Cancer and SARS-CoV-2 negative, Cardioonc ( +) Cardiovascular Disease and Active Cancer and SARS-CoV-2 positive, CVD ( +) Cardiovascular Disease and SARS-CoV-2 positive